Red Marrow Absorbed Dose for non-Hodgkins Lymphoma Patients treated with the novel anti-CD37 antibody radionuclide conjugate 177Lu-lilotomab satetraxetan
Blakkisrud, J., Londalen, A., Dahle, J., Turner, S., Holte, H., Kolstad, A., Stokke, C.Language:
english
Journal:
Journal of Nuclear Medicine
DOI:
10.2967/jnumed.116.180471
Date:
September, 2016
File:
PDF, 924 KB
english, 2016